Introduction 7.622384
: 2.5079741
Ċ 1.0427654
Indian 16.128614
apolis 4.1025953
- 4.493989
based 0.42996395
Ġpharmaceutical 6.8168254
Ġgiant 2.340982
, 2.2123914
ĠEli 4.4026175
ĠLilly 0.008843747
Ġ& 1.978084
ĠCo 0.51905733
, 1.7604866
Ġis 1.6431283
Ġset 2.6715915
Ġto 0.016578702
Ġannounce 3.2908444
Ġits 1.9553945
Ġthird 4.0750146
- 0.8864549
quarter 0.02156908
Ġearnings 0.65547377
, 4.2587247
Ġand 3.4768615
Ġindustry 9.356847
Ġexperts 3.2160723
Ġanticipate 5.344792
Ġa 1.6112716
Ġpositive 3.6502094
Ġtrajectory 6.514813
Ġfor 0.62098926
Ġthe 0.24167025
Ġcompany 0.3217182
. 0.93447876
ĠExpect 8.454792
ations 0.1545504
Ġare 1.0477003
Ġhigh 0.81254864
Ġfor 1.0796483
Ġincreased 6.1175914
Ġprofits 3.1748252
, 1.3025211
Ġdriven 4.968799
Ġby 0.114209205
Ġrobust 5.4220467
Ġsales 2.5743937
Ġof 0.82693446
Ġkey 6.615874
Ġdrugs 2.400641
Ġamid 7.275749
Ġthe 1.913505
Ġongoing 1.8208065
ĠCO 11.315802
VID 10.339365
- 3.7730405
19 6.760046
Ġpand 8.055936
emic 0.005656876
. 0.96005076
ĠHowever 3.7009232
, 0.013459648
Ġanalysts 2.7125266
Ġare 1.2556604
Ġvoicing 8.422231
Ġconcerns 0.9251928
Ġover 1.8650142
Ġpotential 3.792722
Ġprofit 6.7219954
Ġmargin 3.970153
Ġchallenges 4.2600775
Ġfaced 5.9101443
Ġby 0.056344792
Ġthe 0.31558153
Ġcompany 0.1791592
. 0.9836288
ĠThis 3.6126242
Ġarticle 1.5248989
Ġdel 6.3110814
ves 0.0022729393
Ġinto 0.17819867
Ġthe 0.63568
Ġfactors 3.6437776
Ġcontributing 3.580536
Ġto 0.01422337
Ġelevated 8.400505
Ġprofits 1.8823353
, 1.5960766
Ġwhile 3.4684148
Ġexploring 4.343487
Ġthe 0.7735405
Ġunderlying 4.064216
Ġconcerns 6.502868
Ġsurrounding 3.7548714
ĠEli 4.4417963
ĠLilly 0.032273814
Ġ& 1.8917308
ĠCo 0.056389943
's 1.4339863
Ġprofit 3.961531
Ġmargins 1.1789888
. 0.2670608
Ċ 0.2958186
R 9.872504
ising 3.3249943
ĠProf 4.4983983
its 0.15463173
ĠAmid 5.3752227
ĠPand 5.5997934
emic 0.003238757
: 2.4419897
Ċ 3.3193996
E 1.8425882
li 0.02217087
ĠLilly 0.0070207845
Ġ& 0.6057915
ĠCo 0.022004941
's 2.1197376
Ġsteady 9.0206375
Ġsuccess 5.287807
Ġcan 5.7230835
Ġbe 0.25509855
Ġattributed 0.17861612
Ġto 0.1291574
Ġa 2.0074265
Ġrange 4.4181714
Ġof 0.0018304202
Ġfactors 0.34909505
, 0.75330096
Ġincluding 0.6305584
Ġits 1.9177369
Ġstrategic 5.443193
Ġfocus 1.7220826
Ġon 0.85098404
Ġinnovative 4.835693
Ġmedicines 2.1326158
Ġand 1.5480012
Ġstrong 5.470467
Ġproduct 3.2319105
Ġpipeline 2.326242
. 0.4944446
ĠDuring 5.7843943
Ġthe 0.38212988
Ġthird 2.0694144
Ġquarter 0.05898281
, 0.74833447
Ġthe 1.1689857
Ġcompany 0.111290924
Ġwitnessed 6.641503
Ġrobust 4.4805236
Ġsales 0.7874186
Ġof 0.54631436
Ġits 1.512407
Ġblockbuster 3.3527563
Ġdrugs 2.5865924
, 0.870611
Ġsuch 3.3007088
Ġas 0.002086805
ĠTr 6.731093
ul 6.121801
icity 1.0844483
, 0.7180507
ĠT 4.0774245
alt 5.7300944
z 0.96264607
, 0.9962344
Ġand 1.1382821
ĠJ 6.1768475
ard 4.791514
iance 1.964378
, 0.9272105
Ġall 4.210297
Ġof 0.2755124
Ġwhich 0.005199735
Ġcontribute 6.9493117
Ġsignificantly 2.7234914
Ġto 0.028737009
Ġits 1.3899484
Ġbottom 2.484813
Ġline 0.080276094
. 0.21930324
ĠThe 2.3717794
Ġcontinued 6.1537247
Ġdemand 4.463678
Ġfor 0.20437434
Ġthese 0.96627903
Ġmedications 4.5066814
, 2.0596478
Ġcoupled 1.243164
Ġwith 0.0033222986
Ġsuccessful 6.823482
Ġmarketing 3.1542923
Ġstrategies 3.309869
Ġand 2.5038717
Ġenhanced 5.2232194
Ġpatient 3.460562
Ġaccess 4.227505
, 0.6965449
Ġis 2.6212065
Ġanticipated 6.028548
Ġto 0.01796445
Ġdrive 1.6795514
Ġsubstantial 5.327415
Ġrevenue 2.3989909
Ġgrowth 0.21161911
. 1.4772196
Ċ 0.79472065
Additionally 5.5506654
, 0.00340214
ĠEli 1.427697
ĠLilly 0.0030580002
's 2.773795
Ġrecent 4.08735
Ġbreakthrough 6.2424655
Ġin 0.8773796
Ġthe 1.2196685
Ġdevelopment 1.1282973
Ġof 0.07093691
ĠCO 6.3199625
VID 0.21196556
- 0.10232117
19 0.022305068
Ġtreatments 8.997989
Ġhas 2.309411
Ġfurther 3.995
Ġbolstered 3.055674
Ġits 0.48266822
Ġportfolio 6.0214777
. 1.6538162
ĠThe 1.4062446
Ġpharmaceutical 5.560542
Ġcompany 1.643877
's 1.9106908
Ġmon 9.403754
oc 0.0675351
lon 0.046740383
al 0.002504761
Ġantibody 0.22550493
Ġtherapy 4.8455067
, 1.5848199
Ġb 8.382352
am 7.688886
lan 12.891283
iv 6.7972417
im 10.656211
ab 0.5604927
, 0.18813425
Ġreceived 4.8777204
ĠEmergency 14.569292
ĠUse 5.3658934
ĠAuthorization 1.5537646
Ġ( 0.67423445
EU 1.1359665
A 0.35686055
) 0.059028517
Ġfrom 1.516945
Ġthe 0.09496398
ĠUS 2.110922
ĠFood 0.0687843
Ġand 0.034083378
ĠDrug 0.002223953
ĠAdministration 0.0043794643
Ġ( 0.28098187
F 0.01744409
DA 0.0009201949
). 3.3910608
ĠThis 1.5840156
Ġauthorization 4.6804023
Ġenables 3.3049943
ĠEli 2.0493538
ĠLilly 0.004388565
Ġto 0.5019809
Ġsupply 5.7256517
Ġits 3.4263368
Ġpotentially 8.651882
Ġlife 2.085387
- 0.095655374
saving 0.03411483
Ġtreatment 1.517491
Ġto 0.4472944
ĠCO 8.152493
VID 0.0766554
- 0.42854804
19 0.008234419
Ġpatients 0.27014428
, 1.9311792
Ġpotentially 4.172784
Ġleading 3.3703642
Ġto 0.03417558
Ġsubstantial 4.036073
Ġsales 2.3386257
Ġand 3.0113952
Ġfinancial 5.3272185
Ġgains 2.9626744
. 0.5926609
Ċ 0.7023774
Con 6.5007396
cern 0.6025357
s 0.05098068
ĠOver 1.3615322
ĠProfit 1.6911787
ĠMarg 0.0267051
ins 0.73459715
: 0.6083217
Ċ 0.02253914
While 2.6628077
ĠEli 2.3023298
ĠLilly 0.0008082195
Ġ& 0.7510965
ĠCo 0.009519102
's 0.9539135
Ġrising 7.5925503
Ġprofits 0.44274256
Ġdemonstrate 6.4730983
Ġits 1.9565196
Ġstrong 3.2713144
Ġperformance 3.3472104
, 0.7629098
Ġconcerns 4.1830397
Ġpersist 4.0290356
Ġover 1.3089802
Ġprofit 4.024981
Ġmargins 0.13962086
. 0.4640486
ĠThe 1.9526488
Ġescalating 8.75031
Ġcosts 1.7205913
Ġof 0.8345451
Ġresearch 5.324528
Ġand 0.21713902
Ġdevelopment 0.09751749
, 1.576136
Ġcoupled 2.355692
Ġwith 0.001890734
Ġinvestments 8.553621
Ġin 0.21998389
Ġexpanding 4.884929
Ġits 1.2262899
Ġmanufacturing 3.5380464
Ġcapabilities 1.729707
, 0.23488154
Ġhave 1.5369822
Ġsqueezed 8.25345
Ġmargins 1.6477444
Ġfor 2.8568795
Ġthe 0.6360146
Ġcompany 0.19279881
. 0.34765154
ĠAdditionally 4.0765452
, 0.0011749137
Ġincreased 4.3263597
Ġcompetition 1.8900572
Ġwithin 4.336439
Ġthe 0.10596589
Ġpharmaceutical 1.5365982
Ġindustry 0.18139128
, 1.3247964
Ġcombined 3.8310015
Ġwith 0.0006290987
Ġthe 1.6619369
Ġimpending 4.487651
Ġexpiration 3.4371305
Ġof 0.012075529
Ġpatents 4.664936
Ġfor 1.8821429
Ġsome 2.6743467
Ġof 0.34469298
ĠEli 2.0796828
ĠLilly 0.0007695058
's 0.8207201
Ġkey 2.0134907
Ġdrugs 1.306515
, 0.11005707
Ġposes 4.4476767
Ġpotential 4.0281115
Ġpricing 6.182802
Ġchallenges 1.4820427
. 0.77807635
Ċ 0.99850404
Moreover 6.1970315
, 0.0011420337
Ġongoing 6.2756925
Ġdiscussions 4.588674
Ġon 4.134249
Ġdrug 4.761705
Ġpricing 0.8235345
Ġreforms 7.299631
Ġwithin 2.4903944
Ġthe 0.079399
ĠUS 1.1202881
Ġhealthcare 3.0236013
Ġsystem 1.4314152
Ġcould 3.1474164
Ġsignificantly 4.7696505
Ġimpact 1.1040694
Ġthe 1.3194895
Ġoverall 4.7656174
Ġprofitability 1.1762514
Ġof 0.08268358
Ġpharmaceutical 4.918407
Ġcompanies 0.29712301
Ġlike 4.8864408
ĠEli 0.014176032
ĠLilly 0.0006389395
. 1.2075341
ĠPossible 8.5581455
Ġchanges 2.5134752
Ġto 1.0169916
Ġdrug 2.5167599
Ġpricing 0.27316895
Ġpolicies 1.834178
Ġand 2.5628927
Ġincreased 4.194133
Ġpressure 5.22404
Ġfor 2.9218018
Ġaffordable 6.4693966
Ġaccess 2.2903023
Ġto 0.4466503
Ġmedications 2.9792662
Ġcould 1.1022832
Ġimpact 3.6177356
Ġthe 1.1567663
Ġcompany 1.3956616
's 0.11578966
Ġpricing 6.0587263
Ġpower 4.114487
Ġand 2.043517
Ġexert 9.609131
Ġdownward 2.3103034
Ġpressure 0.022516523
Ġon 0.03956512
Ġmargins 2.9884033
. 0.14117858
Ċ 0.31713536
Out 8.906103
look 0.23164858
Ġand 4.366255
ĠStrategies 4.4688053
: 0.42635244
Ċ 0.008299807
Despite 2.792889
Ġthe 1.1321521
Ġconcerns 6.50423
Ġsurrounding 1.779128
Ġprofit 1.5136305
Ġmargins 0.058013584
, 0.15463716
ĠEli 1.0050625
ĠLilly 0.00019237537
Ġ& 0.55911607
ĠCo 0.0059311516
Ġremains 2.7053554
Ġoptimistic 1.521621
Ġabout 0.8044327
Ġits 0.7195494
Ġfuture 1.4603887
Ġgrowth 3.2591083
Ġprospects 0.5683229
. 0.3218945
ĠThe 0.9159376
Ġpharmaceutical 4.310195
Ġmanufacturer 5.8336935
Ġcontinues 3.486037
Ġto 0.026560513
Ġadvance 6.611411
Ġits 0.4733804
Ġrobust 7.7779565
Ġresearch 3.5050404
Ġand 0.31243074
Ġdevelopment 0.102749124
Ġpipeline 2.631396
, 0.45950818
Ġfocusing 5.0577793
Ġon 0.12530568
Ġinnovative 2.8075778
Ġtherapies 3.2274792
Ġfor 2.1301506
Ġvarious 3.8595788
Ġdiseases 1.0550411
. 0.73951906
ĠMoreover 3.9740632
, 0.00048298642
Ġthe 0.7727181
Ġcompany 0.1741574
Ġstrateg 9.87465
izes 0.4393268
Ġto 1.0677377
Ġexpand 2.4877503
Ġits 0.28677937
Ġglobal 3.006592
Ġpresence 2.429755
Ġthrough 2.2307527
Ġpartnerships 3.194851
Ġand 1.6850152
Ġacquisitions 1.1786873
, 0.8790562
Ġaiming 4.8810387
Ġto 0.13178834
Ġdivers 3.9381874
ify 0.0012500489
Ġits 0.21438062
Ġrevenue 3.6979415
Ġstreams 0.5711371
Ġand 1.1589562
Ġreduce 4.5070076
Ġdependency 5.90264
Ġon 0.018821754
Ġindividual 7.210241
Ġblockbuster 6.3287883
Ġdrugs 0.41694883
. 0.08028048
Ċ 0.47336286
E 3.2640135
li 0.02784378
ĠLilly 0.0008648324
Ġ& 0.56962043
ĠCo 0.008475255
Ġis 2.1730318
Ġalso 2.6342669
Ġengaging 6.953682
Ġin 0.34088412
Ġongoing 4.9023585
Ġefforts 2.1460059
Ġto 0.08662938
Ġmanage 6.343023
Ġcosts 2.829867
Ġeffectively 5.1917186
Ġand 2.629012
Ġoptimize 4.274332
Ġits 0.8378073
Ġmanufacturing 3.7264302
Ġprocesses 1.3848503
. 0.48115012
ĠBy 4.388046
Ġenhancing 4.330526
Ġoperational 5.880042
Ġeffic 1.0597202
iencies 2.272356e-05
Ġand 1.1370903
Ġexploring 7.0525627
Ġtechnological 6.2639832
Ġadvancements 1.6025089
, 0.35979065
Ġthe 0.110519215
Ġcompany 0.06105017
Ġaims 1.4316212
Ġto 0.014388372
Ġcounter 6.8324366
Ġthe 1.052749
Ġchallenges 2.7593503
Ġposed 1.518679
Ġby 0.021229047
Ġrising 2.0231917
Ġcosts 0.8227402
Ġand 1.2375525
Ġpotential 5.400843
Ġpricing 3.7993505
Ġpressures 1.2868413
. 0.17907
Ċ 0.80470216
Conclusion 3.6946833
: 0.024907717
Ċ 0.024758503
E 0.9411755
li 0.0026707135
ĠLilly 0.00021228698
Ġ& 0.1434834
ĠCo 0.004638842
's 1.2896388
Ġthird 3.6842015
- 0.18485542
quarter 0.0046078814
Ġearnings 0.5557387
Ġare 2.1681414
Ġexpected 0.6735467
Ġto 0.015551427
Ġshowcase 5.962793
Ġa 1.560053
Ġstrong 2.1038182
Ġupward 7.8953433
Ġtrajectory 0.5127916
Ġin 2.46175
Ġprofits 2.259602
, 1.0303166
Ġprimarily 5.453277
Ġfueled 3.8153522
Ġby 0.0035495765
Ġrobust 2.9718754
Ġsales 0.2120108
Ġof 0.041240785
Ġtheir 6.5266323
Ġblockbuster 1.3961927
Ġdrugs 0.5504069
Ġand 3.0013368
Ġbreakthrough 6.676232
s 1.3601216
Ġin 0.084154636
ĠCO 2.6792724
VID 0.02726454
- 0.017903464
19 0.0027576739
Ġtreatments 1.9032533
. 0.07515048
ĠHowever 1.702294
, 0.0032644102
Ġconcerns 2.723817
Ġlinger 4.330272
Ġover 0.5904042
Ġtheir 6.1585546
Ġprofit 2.2907977
Ġmargins 0.09260631
, 0.46695915
Ġstemming 6.314664
Ġfrom 0.10396415
Ġrising 3.5424674
Ġcosts 0.17716864
Ġof 1.9715364
Ġresearch 0.6026277
Ġand 0.01192743
Ġdevelopment 0.0142802615
, 0.8066863
Ġpotential 5.811321
Ġpricing 1.228368
Ġpressures 1.1111926
, 0.2574295
Ġand 0.09432881
Ġdrug 7.5962625
Ġpricing 1.0786732
Ġreforms 0.50456685
. 0.6502448
ĠThe 2.6670756
Ġcompany 0.4006875
's 1.5242836
Ġfuture 4.1966195
Ġsuccess 2.5098457
Ġhinges 1.8439364
Ġon 0.15323251
Ġits 1.2797515
Ġability 0.3008884
Ġto 0.002797601
Ġeffectively 4.1184134
Ġmanage 0.091151185
Ġthese 1.4661448
Ġchallenges 0.85113484
, 1.0755843
Ġwhile 1.3339835
Ġcontinuing 3.7606633
Ġto 0.04648054
Ġinnovate 3.215833
Ġand 0.8143127
Ġexpand 2.2370658
Ġits 0.15739581
Ġproduct 2.0058248
Ġportfolio 0.3497062
. 0.2721523
